| |
 |
|
Class Information
Number: 514/181
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Cyclopentanohydrophenanthrene ring system doai > Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system > Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system > 21-position substituted
Description: Subject matter wherein the carbon in the 21 position is directly bonded to an atom other than carbon or hydrogen.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7566705 |
Combination of formoterol and mometasone furoate for asthma |
Jul. 28, 2009 |
| 7553829 |
Treatment of chronic fatigue syndrome and fibromyalgia syndrome |
Jun. 30, 2009 |
| 7528123 |
Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11 |
May. 5, 2009 |
| 7479486 |
Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids |
Jan. 20, 2009 |
| 7456161 |
Use of DHEA and DHEA-sulfate for the treatment of chronic obstructive pulmonary disease |
Nov. 25, 2008 |
| 7442386 |
Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies |
Oct. 28, 2008 |
| 7378405 |
Stabilized steroid composition and method for its preparation |
May. 27, 2008 |
| 7345035 |
Treatment of osteoporosis and autoimmune disease with astrogorgiadiol |
Mar. 18, 2008 |
| 7335650 |
Composition |
Feb. 26, 2008 |
| 7192941 |
Estradiol metabolites for the treatment of pulmonary hypertension |
Mar. 20, 2007 |
| 7163934 |
Methods for treating delirium glucocorticoid receptor-specific antagonists |
Jan. 16, 2007 |
| 7148213 |
Antigestagenically active steroids with a fluorinated 17.alpha.-alkyl chain |
Dec. 12, 2006 |
| 7067502 |
Combinations of formoterol and mometasone furoate for asthma |
Jun. 27, 2006 |
| 7053074 |
Prevention of ovarian cancer by administration of a Vitamin D compound |
May. 30, 2006 |
| 6995149 |
Contraceptive process and kit for female mammals, comprising a combination of gestagen and oestrogen |
Feb. 7, 2006 |
| 6958212 |
Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
Oct. 25, 2005 |
| 6844320 |
Treatment of preeclampsia, toxemia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor |
Jan. 18, 2005 |
| 6835724 |
Corticoid 17,21-dicarboxylic esters and corticosteroid 17-carboxylic ester 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds |
Dec. 28, 2004 |
| 6806263 |
Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain |
Oct. 19, 2004 |
| 6803060 |
Composition to boost libido |
Oct. 12, 2004 |
| 6762175 |
Fatty acid derivatives |
Jul. 13, 2004 |
| 6656970 |
Method and compositions for solubilization of pentacyclic triterpenes |
Dec. 2, 2003 |
| 6617319 |
Methods of use for 2-deoxy ecdysterone |
Sep. 9, 2003 |
| 6610674 |
Method of treating inflammatory conditions with progesterone analogs |
Aug. 26, 2003 |
| 6579862 |
Method of treating hyperlipidemic and hyperglycemic conditions in mammals using pregnadienols and pregnadienones |
Jun. 17, 2003 |
| 6514516 |
Formulations and methods for providing prolonged local anesthesia |
Feb. 4, 2003 |
| 6511970 |
Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium |
Jan. 28, 2003 |
| 6479475 |
Oral contraceptive |
Nov. 12, 2002 |
| 6468994 |
Budesonide particles and pharmaceutical compositions containing them |
Oct. 22, 2002 |
| 6395746 |
Methods of treating ophthalmic, otic and nasal infections and attendant inflammation |
May. 28, 2002 |
| 6369115 |
Stabilized powder formulations |
Apr. 9, 2002 |
| 6365580 |
Process for the production of difluoromethane |
Apr. 2, 2002 |
| 6350739 |
Methods of prevention and treatment of ischemic damage |
Feb. 26, 2002 |
| 6346523 |
Budesonide particles and pharmaceutical compositions containing them |
Feb. 12, 2002 |
| 6339078 |
Methods of prevention and treatment of ischemic damage |
Jan. 15, 2002 |
| 6329380 |
SRC kinase inhibitor compounds |
Dec. 11, 2001 |
| 6326365 |
Methods of prevention and treatment of ischemic damage |
Dec. 4, 2001 |
| 6319914 |
Cytoprotective effect of polycyclic phenolic compounds |
Nov. 20, 2001 |
| 6316432 |
Antigestagenically active steroids with a flourinated 17 .alpha.-alkyl chain |
Nov. 13, 2001 |
| 6228850 |
Antiangiogenic activity of betulinic acid and its derivatives |
May. 8, 2001 |
| 6197761 |
17.beta.-2-oxo-tetrahydrofuranyl)-carbothioic acid ester, -carboxylic acid ester and -carboxylic acid amide androstane derivatives |
Mar. 6, 2001 |
| 6172088 |
Testosterone compounds and use for the protection of neurons |
Jan. 9, 2001 |
| 6172055 |
Apoptosis inhibitors for treating neurodegenerative diseases |
Jan. 9, 2001 |
| 6143738 |
Therapeutic uses for an aminosterol compound |
Nov. 7, 2000 |
| 6143736 |
Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
Nov. 7, 2000 |
| 6117860 |
Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia |
Sep. 12, 2000 |
| 6114348 |
Method of treating warts using tazarotene |
Sep. 5, 2000 |
| 6107276 |
Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent |
Aug. 22, 2000 |
| 6096731 |
Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation |
Aug. 1, 2000 |
| 6093389 |
Methods and compositions for attracting and controlling termites |
Jul. 25, 2000 |
|
|
|
